Related Experiment Video
Updated: May 21, 2026
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer
Tonya J Webb1, Xiangming Li, Robert L Giuntoli
1Department of Pathology and The Kelly Gynecologic Oncology Service, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21201, USA. twebb@som.umaryland.edu
Abstract:
Tumors often display mechanisms to avoid or suppress immune recognition. One such mechanism is the shedding of gangliosides into the local tumor microenvironment, and a high concentration of circulating gangliosides is associated with poor prognosis. In this study, we identify ganglioside GD3, which was isolated from the polar lipid fraction of ovarian cancer-associated ascites, as an inhibitory factor that prevents innate immune activation of natural killer T (NKT) cells. Purified GD3 displayed a high affinity for both human and mouse CD1d, a molecule involved in the presentation of lipid antigens to T cells. Purified GD3, as well as substances within the ascites, bound to the CD1d antigenic-binding site and did not require additional processing for its inhibitory effect on NKT cells. Importantly, in vivo administration of GD3 inhibited α-galactosylceramide (α-GalCer)-induced NKT cell activation in a dose-dependent manner. These data therefore indicate that ovarian cancer tumors may use GD3 to inhibit the antitumor NKT cell response as an early mechanism of tumor immune evasion.
Insights
Ovarian cancers release ganglioside GD3 to suppress immune responses. This molecule inhibits natural killer T (NKT) cells by binding to CD1d, aiding tumor immune evasion.
Area of Science:
- Immunology
- Oncology
- Glycobiology
Background:
- Tumors evade immune detection through various mechanisms.
- Gangliosides shed by tumors can suppress immune responses and are linked to poor prognosis.
Purpose of the Study:
- To identify specific gangliosides involved in ovarian cancer immune evasion.
- To investigate the mechanism by which gangliosides inhibit natural killer T (NKT) cell activation.
Main Methods:
- GD3 ganglioside was isolated from ovarian cancer ascites.
- Binding affinity of GD3 to CD1d was assessed in vitro.
- In vivo studies using mice evaluated the effect of GD3 on NKT cell activation.
Main Results:
- Ganglioside GD3 was identified as an inhibitor of NKT cell activation.
- GD3 binds directly to the CD1d molecule, preventing lipid antigen presentation.
- In vivo administration of GD3 dose-dependently inhibited NKT cell responses.
Conclusions:
- Ovarian cancer utilizes GD3 to suppress the antitumor NKT cell response.
- GD3 acts as an early immune evasion mechanism for ovarian tumors.
- Targeting GD3 may restore NKT cell-mediated antitumor immunity.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
10:00Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy
Published on: November 8, 2016
Related Concept Videos
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:25Inflammatory Bowel Disease III: Crohn's Disease